A detailed history of Deka Bank Deutsche Girozentrale transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 11,185 shares of LGND stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,185
Previous 11,185 -0.0%
Holding current value
$1.24 Million
Previous $923,000 16.9%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$58.86 - $72.67 $69,749 - $86,113
1,185 Added 11.85%
11,185 $687,000
Q3 2022

Nov 02, 2022

BUY
$0.01 - $107.56 $54 - $587,277
5,460 Added 120.26%
10,000 $847,000
Q1 2022

Apr 28, 2022

BUY
$94.99 - $151.56 $37,996 - $60,624
400 Added 9.66%
4,540 $527,000
Q4 2021

Feb 02, 2022

BUY
$127.69 - $165.85 $12,769 - $16,585
100 Added 2.48%
4,140 $669,000
Q4 2020

Mar 12, 2021

SELL
$80.55 - $106.05 $16,110 - $21,210
-200 Reduced 4.72%
4,040 $396,000
Q3 2020

Oct 29, 2020

BUY
$89.56 - $126.72 $379,734 - $537,292
4,240 New
4,240 $400,000
Q4 2019

Feb 04, 2020

SELL
$96.94 - $113.59 $784,244 - $918,943
-8,090 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$86.25 - $120.16 $740,887 - $1.03 Million
-8,590 Reduced 51.5%
8,090 $801,000
Q2 2019

Aug 01, 2019

BUY
$107.38 - $129.34 $788,169 - $949,355
7,340 Added 78.59%
16,680 $1.9 Million
Q1 2019

May 10, 2019

BUY
$105.93 - $142.47 $105,930 - $142,470
1,000 Added 11.99%
9,340 $2.41 Million
Q4 2018

Feb 12, 2019

SELL
$128.36 - $272.13 $128,360 - $272,130
-1,000 Reduced 10.71%
8,340 $1.14 Million
Q3 2018

Nov 09, 2018

SELL
$211.18 - $274.49 $50,683 - $65,877
-240 Reduced 2.51%
9,340 $0
Q1 2018

May 03, 2018

SELL
$138.63 - $182.62 $26,339 - $34,697
-190 Reduced 1.94%
9,580 $1.55 Million
Q3 2017

Nov 06, 2017

BUY
$120.91 - $137.94 $1.18 Million - $1.35 Million
9,770
9,770 $1.25 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.87B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.